T-CHARGE Trademark

Trademark Overview

On Tuesday, October 5, 2021, a trademark application was filed for T-CHARGE with the United States Patent and Trademark Office. The USPTO has given the T-CHARGE trademark a serial number of 79325779. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by NOVARTIS AG. The T-CHARGE trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Treatment of biopharmaceutical materials; custom manufacturing to the order and requirements of a customer of cells and vectors for diagnostic and medical applications in relation to cell and gene therapies
t-charge

General Information

Serial Number79325779
Word MarkT-CHARGE
Filing DateTuesday, October 5, 2021
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6726955
Registration DateTuesday, May 24, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2022

Trademark Statements

Goods and ServicesTreatment of biopharmaceutical materials; custom manufacturing to the order and requirements of a customer of cells and vectors for diagnostic and medical applications in relation to cell and gene therapies

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, November 19, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Sunday, September 4, 2022NOTIFICATION PROCESSED BY IB
Thursday, August 18, 2022FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, August 17, 2022FINAL DISPOSITION PROCESSED
Thursday, June 23, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, May 24, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, March 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2022PUBLISHED FOR OPPOSITION
Monday, February 28, 2022NOTIFICATION PROCESSED BY IB
Wednesday, February 9, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 9, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 26, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, January 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 21, 2022ASSIGNED TO EXAMINER
Tuesday, November 23, 2021APPLICATION FILING RECEIPT MAILED
Friday, November 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 18, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

charge applications medical diagnostic relation cell therapies gene vectors cells custom